Lobbying Disclosure: Pharmaceutical Research and Manufacturers of America (Q1 2000)
June 20, 2026
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
The Frame
This report identifies the financial investment made by a major pharmaceutical industry trade group to influence specific state legislation and during the 2000 legislative session.
Potentially affected actors named in the source documents. Mention is not a position.
Pharmaceutical Research and Manufacturers of America
The organization paid for lobbying services to influence state legislative and regulatory outcomes.
Noteware and Shannon
The firm received payment to perform lobbying services on behalf of their client.
Last recorded activity June 20, 2026.
Next step not available in the current record.
Summary
Key Facts
- Total lobbying payments for the period of 1/1/2000 to 3/31/2000 were $21,875.
- Lobbying activity focused on the 2000 State Budget regarding the Department of Health Services.
- Lobbying activity included monitoring regulatory oversight by the Department of Managed Care.
- The firm lobbied on Assembly Bill (AB) 1722, 1915, 1953, 2018, 2038, 2077, 2185, 2294, 2533, 2804, and Assembly Joint Resolution (AJR) 42.
- The firm lobbied on Senate Bill (SB) 1364, 1419, 1601, 1828, 1880, 1903, 1940, 2075, and Senate Joint Resolution (SJR) 29.
Why It Matters
This report identifies the financial investment made by a major pharmaceutical industry trade group to influence specific state legislation and during the 2000 legislative session.
Frequently Asked Questions
How much was spent on lobbying during this period?
Which state agencies were the focus of this lobbying activity?
News Coverage
Lobbying Activity
NOTEWARE AND SHANNON
on behalf of PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Broad Legislative Engagement
The client engaged with a high volume of legislative items (20+ bills and resolutions) in a single quarter, indicating a broad interest in the 2000 legislative session.
Connected Entities
Sources
www.sos.ca.gov
Analysis Score
0–100- Significance40How much this matters to a regular citizen
- Controversy20Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz10Current news / social attention level
Publisher tools